We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+19.16%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$487M
AUM Growth
+$111M
Cap. Flow
+$68.8M
Cap. Flow %
14.14%
Top 10 Hldgs %
24.68%
Holding
170
New
47
Increased
65
Reduced
33
Closed
18

Top Sells

Rank Stock Value
1
REXR icon
Rexford Industrial Realty
REXR
+$5.1M
2
SF
Stifel
SF
+$4.64M
3
SHOO icon
Steven Madden
SHOO
+$4.62M
4
SWX icon
Southwest Gas
SWX
+$4.27M
5
DORM icon
Dorman Products
DORM
+$4.22M

Sector Composition

Rank Sector Weight
1 Industrials 14.37%
2 Healthcare 14.2%
3 Technology 14.06%
4 Financials 13.48%
5 Consumer Discretionary 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBH icon
76
KB Home
KBH
$3.59B
$2.59M 0.53%
+75,705
New +$2.62M
NVCR icon
77
NovoCure
NVCR
$1.91B
$2.59M 0.53%
30,751
+885
+3% +$71.4K
HAE icon
78
Haemonetics
HAE
$4B
$2.52M 0.52%
21,973
+197
+0.9% +$23.8K
ASND icon
79
Ascendis Pharma A/S
ASND
$16.8B
$2.52M 0.52%
+18,145
New +$2.02M
AMN icon
80
AMN Healthcare
AMN
$1.4B
$2.42M 0.5%
38,764
+354
+0.9% +$20.9K
CHX
81
DELISTED
ChampionX
CHX
$2.41M 0.5%
+71,440
New +$1.95M
IOVA icon
82
Iovance Biotherapeutics
IOVA
$2.83B
$2.35M 0.48%
84,874
+1,311
+2% +$29.8K
CRUS icon
83
Cirrus Logic
CRUS
$6.26B
$2.31M 0.47%
+27,994
New +$1.9M
HQY icon
84
HealthEquity
HQY
$8.75B
$2.27M 0.47%
30,595
+7,337
+32% +$458K
FIX icon
85
Comfort Systems
FIX
$59.6B
$2.25M 0.46%
45,129
+704
+2% +$34.2K
SEDG icon
86
SolarEdge
SEDG
$1.95B
$2.21M 0.45%
23,204
+401
+2% +$34.3K
SSD icon
87
Simpson Manufacturing
SSD
$8.16B
$2.12M 0.43%
+26,356
New +$2.05M
AZTA icon
88
Azenta
AZTA
$1.48B
$1.96M 0.4%
46,645
-19,570
-30% -$822K
KRTX
89
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.94M 0.4%
+25,804
New +$1.13M
ENPH icon
90
Enphase Energy
ENPH
$5.53B
$1.89M 0.39%
72,266
-4,026
-5% -$91.6K
AIN icon
91
Albany International
AIN
$1.78B
$1.88M 0.39%
24,798
-47,467
-66% -$3.94M
DRNA
92
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.76M 0.36%
+79,961
New +$1.61M
NTRA icon
93
Natera
NTRA
$46.1B
$1.7M 0.35%
50,412
+447
+0.9% +$16.5K
ROG icon
94
Rogers Corp
ROG
$2.4B
$1.63M 0.34%
13,084
-571
-4% -$77.2K
BPMC
95
DELISTED
Blueprint Medicines
BPMC
$1.48M 0.31%
18,522
-736
-4% -$55.1K
NVTA
96
DELISTED
Invitae Corporation
NVTA
$1.45M 0.3%
89,733
+20,104
+29% +$356K
KSS icon
97
Kohl's
KSS
$2.19B
$1.19M 0.24%
23,327
COF icon
98
Capital One
COF
$134B
$1.09M 0.22%
10,580
ALLY icon
99
Ally Financial
ALLY
$13.3B
$1.04M 0.21%
34,168
-4,826
-12% -$151K
RHI icon
100
Robert Half
RHI
$4.37B
$967K 0.2%
+15,317
New +$889K

Similar funds

Moody Aldrich Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Moody Aldrich Partners held 170 positions worth $487M, up 29% from $376M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Moody Aldrich Partners deployed $68.8M of net new capital in Q4 2019, opening 47 new positions and adding to 65 existing holdings. Its largest new stake was iShares MSCI ACWI ETF: 579,000 shares worth $45.9M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Rexford Industrial Realty, an estimated $5.1M trimmed.

  • Moody Aldrich Partners's largest Q4 2019 buy was iShares MSCI ACWI ETF: 579,000 shares worth $45.9M.
  • Moody Aldrich Partners added most to Marriott Vacations Worldwide in Q4 2019, an estimated $2.55M increase.
  • Moody Aldrich Partners's biggest Q4 2019 reduction was Rexford Industrial Realty, cutting an estimated $5.1M.
  • Moody Aldrich Partners fully exited Stifel in Q4 2019, selling an estimated $4.64M.
  • Moody Aldrich Partners's ten largest holdings make up 25% of its $487M portfolio in Q4 2019.
  • Moody Aldrich Partners opened 47 new positions and closed 18 in Q4 2019.
  • Moody Aldrich Partners's portfolio value rose 29% quarter-over-quarter to $487M.

Based on Moody Aldrich Partners's 13F filing for Q4 2019, filed 7 Feb 2020.